Use of Cefiderocol in the Management of Children With Infection or Colonization With Multi-drug Resistant Gram-negative Bacteria: A Retrospective, Single-center Case Series

被引：1
|
作者：
Schmid, Hanna [1 ]
Brown, Li-An K. [2 ]
Indrakumar, Bairavi [3 ]
McGarrity, Orlagh [3 ]
Hatcher, James [2 ]
Bamford, Alasdair [1 ,4 ]
机构：
[1] Great Ormond St Hosp Children NHS Fdn Trust, Paediat Infect Dis, Great Ormond St, London WC1N 3JH, England
[2] Great Ormond St Hosp Children NHS Fdn Trust, Dept Microbiol, Lab Med, London, England
[3] Great Ormond St Hosp Children NHS Fdn Trust, Pharm Dept, London, England
[4] UCL Great Ormond St Inst Child Hlth, Infect Immun & Inflammat Dept, London, England
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2024年 / 43卷 / 08期
关键词：
antimicrobial resistance; cefiderocol; multidrug-resistant Gram-negative bacteria; novel antimicrobials; pediatric;
D O I：
10.1097/INF.0000000000004347
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Cefiderocol, a novel siderophore cephalosporin, represents a treatment option for infections with multidrug-resistant Gram-negative bacteria, of which rates are rising worldwide. Clinical data on its use in children is limited. In our pediatric case series, the largest reported to date, cefiderocol seems safe and well tolerated, with more favorable clinical outcomes when compared to the literature reviewing adult cases.
引用
收藏
页码：772 / 776
页数：5
相关论文
共 50 条
  • [1] Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections
    El Ghali, Amer
    Coyne, Ashlan J. Kunz
    Lucas, Kristen
    Tieman, Molly
    Xhemali, Xhilda
    Lau, Suet-ping
    Iturralde, Gabriela
    Purdy, Andrew
    Holger, Dana J.
    Garcia, Esther
    Veve, Michael P.
    Rybak, Michael J.
    MICROBIOLOGY SPECTRUM, 2024, 12 (02)
  • [2] Successful outpatient parenteral antibiotic therapy with cefiderocol for osteomyelitis caused by multi-drug resistant Gram-negative bacteria: a case report
    Schellong, Paul
    Wennek-Klose, Janett
    Spiegel, Christian
    Roedel, Juergen
    Hagel, Stefan
    JAC-ANTIMICROBIAL RESISTANCE, 2023, 6 (01):
  • [3] The use of cefiderocol for extensively drug-resistant gram-negative bacterial infections: a case series
    Sadyrbaeva-Dolgova, S.
    Martin-Roldan, A.
    Espinosa-Rodriguez, A.
    Jimenez-Morles, A.
    Hidalgo-Tenorio, C.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1553 - 1554
  • [4] Antibiotic susceptibility and biofilm formation of multi-drug resistant Gram-negative bacteria
    Oyardi, Ozlem
    Hacioglu, Mayram
    Yilmaz, Fatima Nur
    Inan, Nese
    Tan, Ayse Seher Birteksoz
    ISTANBUL JOURNAL OF PHARMACY, 2023, 53 (01): : 45 - 50
  • [5] Use of Cefiderocol in Management of Resistant Gram-Negative Infections in Patients Admitted to a Burn Center
    Lane, Lindey C.
    Walker, Jonathon K.
    Hill, David M.
    MICROORGANISMS, 2025, 13 (02)
  • [6] Colonization and Infection With Extensively Drug Resistant Gram-Negative Bacteria in Liver Transplant Recipients
    Massa, E.
    Michailidou, E.
    Agapakis, D.
    Papadopoulos, S.
    Tholioti, T.
    Aleuroudis, I.
    Bargiota, T.
    Passakiotou, M.
    Daoudaki, M.
    Antoniadis, N.
    Imvrios, G.
    Iosifidis, E.
    Vagdatli, E.
    Roilides, E.
    Vasilakos, D.
    Fouzas, I.
    Mouloudi, E.
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (02) : 454 - 456
  • [7] Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria
    Liu, Yuan
    Li, Ruichao
    Xiao, Xia
    Wang, Zhiqiang
    CRITICAL REVIEWS IN MICROBIOLOGY, 2019, 45 (03) : 301 - 314
  • [8] Equisetin Restores Colistin Sensitivity against Multi-Drug Resistant Gram-Negative Bacteria
    Zhang, Qi
    Chen, Shang
    Liu, Xiaojia
    Lin, Wenhan
    Zhu, Kui
    ANTIBIOTICS-BASEL, 2021, 10 (10):
  • [9] THE DISEASE BURDEN AND HEALTHCARE RESOURCE UTILIZATION OF GRAM-NEGATIVE MULTI-DRUG RESISTANT BACTERIA
    Young, J.
    Pacis, S.
    Bolzani, A.
    Wilke, T.
    Fuchs, A.
    VALUE IN HEALTH, 2023, 26 (12) : S245 - S246
  • [10] Ceftolozane/Tazobactam and Ceftazidime/Avibactam: An Italian Multi-center Retrospective Analysis of Safety and Efficacy in Children With Hematologic Malignancies and Multi-drug Resistant Gram-negative Bacteria Infections
    Perruccio, Katia
    D'Amico, Maria Rosaria
    Baretta, Valentina
    Onofrillo, Daniela
    Carraro, Francesca
    Calore, Elisabetta
    Muggeo, Paola
    Colombini, Antonella
    Zama, Daniele
    Meazza, Cristina
    Cesaro, Simone
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2022, 41 (12) : 994 - 996
12345